4548 On Other Exchanges
Symbol
Exchange
4548 is not on other exchanges.

seikagaku corp (4548) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SEIKAGAKU CORP (4548)

Related News

No related news articles were found.

seikagaku corp (4548) Related Businessweek News

No Related Businessweek News Found

seikagaku corp (4548) Details

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. The company operates through, Pharmaceuticals and LAL segments. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, SUPARTZ FX, ARTZAL, etc.; ophthalmic surgical aids under the brands OPEGAN, OPEGAN Hi, and SHELLGAN; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and cross-linked hyaluronate hydrogel for knee osteoarthritis under the brand name of Gel-One. The company also provides bulk products comprising sodium hyaluronate, which is used as a raw material for the manufacturers of pharmaceuticals; and sodium chondroitin sulfate that is used as a raw material in pharmaceuticals, ophthalmic products, and drinks for nutritional fortification. In addition, it develops endotoxin-detecting reagents for use in quality control in the manufacturing process and release test of pharmaceuticals and medical devices, as well as in quality management of fluids for hemodialysis under the Pyrochrome, ENDOSPECY, TOXICOLOR, etc. brands. Further, the company develops and markets oral care products comprising mouthwash under the KINUSUI Spray brand. Additionally, its products under development include SI-6603 that is in Phase III clinical trials for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; and SI-613, a formulation for knee osteoarthritis. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

687 Employees
Last Reported Date: 05/12/17
Founded in 1947

seikagaku corp (4548) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

seikagaku corp
Seikagaku Corporation, Annual General Meeting, Jun 20, 2017

Seikagaku Corporation, Annual General Meeting, Jun 20, 2017, at 10:00 Tokyo Standard Time. Location: Hall 4th Otemachi Sankei Plaza 7-2 Otemachi-ku, Chiyoda-ku Tokyo Japan

Seikagaku Corp. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Consolidated and Non-Consolidated Earnings Guidance for the Year Ending March 31, 2018

Seikagaku Corp. reported consolidated and non-consolidated earnings results for the year ended March 31, 2017. For the year, on consolidated basis, the company reported net sales of JPY 29,589 million against JPY 30,962 million a year ago. Operating income was JPY 1,282 million against JPY 2,144 million a year ago. Ordinary income was JPY 2,477 million against JPY 3,500 million a year ago. Net income attributable to owners of the parent was JPY 1,787 million or JPY 31.55 per share against JPY 2,578 million or JPY 45.39 per share a year ago. Return on equity was 2.5% against 3.7% a year ago. Net cash flows from operating activities were JPY 4,885 million against JPY 5,595 million a year ago. For the year, on non-consolidated basis, the company reported net sales of JPY 25,460 million against JPY 26,824 million a year ago. Operating income was JPY 293 million against JPY 1,195 million a year ago. Ordinary income was JPY 1,487 million against JPY 2,553 million a year ago. Net income was JPY 1,165 million or JPY 20.58 per share against JPY 2,000 million or JPY 35.22 per share a year ago. For the year ending March 31, 2018, on consolidated basis, the company expects net sales of JPY 30,300 million, operating income of JPY 1,500 million, ordinary income of JPY 3,750 million and net income attributable to owners of parent of JPY 2,700 or JPY 47.65 per share. For the fiscal 2018, the company expects a 2.4% increase in net sales year on year to JPY 30,300 million, as a result of expected sales increases for Gel-One and the overseas LAL business.

Seikagaku Corporation, 2017 Earnings Call, May 15, 2017

Seikagaku Corporation, 2017 Earnings Call, May 15, 2017

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4548 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4548.
View Industry Companies
 

Industry Analysis

4548

Industry Average

Valuation 4548 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SEIKAGAKU CORP, please visit www.seikagaku.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.